Prices delayed by at least 15 minutes | Print
Arecor Therapeutics PLC (AREC)
ORD GBP0.01This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing medicines to market through the enhancement of existing therapeutic products. By applying an proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.
Address
Chesterford Research Park
Little Chesterford
Saffron Walden
GBR
CB10 1XL
Telephone
+44 1223426060
Forecast key dates
| Name | Key Date |
|---|---|
| Arecor Therapeutics PLC Fourth Quarter Earnings Results for 2025 | 2026-04-22T00:00:00 |
| Arecor Therapeutics PLC Fourth Quarter Earnings Conference Call for 2025 | 2026-04-22T00:00:00 |
| Arecor Therapeutics PLC Second Quarter Earnings Conference Call for 2025 | 2025-09-26T09:30:00 |
| Arecor Therapeutics PLC Second Quarter Earnings Results for 2025 | 2025-09-26T00:00:00 |
| Arecor Therapeutics PLC Annual General Meeting for 2024 | 2025-06-27T12:00:00 |
| Arecor Therapeutics PLC Annual Report for 2024 | 2025-05-30T00:00:00 |
| Arecor Therapeutics PLC Fourth Quarter Earnings Result for 2024 | 2025-04-22T00:00:00 |
| Arecor Therapeutics PLC Fourth Quarter Earnings Conference Call for 2024 | 2025-04-22T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Arecor Therapeutics PLC Fourth Quarter Earnings Result for 2024 | 2025-04-22T00:00:00 |
| Arecor Therapeutics PLC Fourth Quarter Earnings Conference Call for 2024 | 2025-04-22T00:00:00 |
| Arecor Therapeutics PLC Second Quarter Earnings Conference Call for 2024 | 2024-09-26T09:30:00 |
| Arecor Therapeutics PLC Second Quarter Earnings Result for 2024 | 2024-09-26T00:00:00 |
| Arecor Therapeutics PLC Annual General Meeting for 2023 | 2024-06-28T12:00:00 |
| Arecor Therapeutics PLC Annual Report for 2023 | 2024-05-31T00:00:00 |
| Arecor Therapeutics PLC Fourth Quarter Earnings Results for 2023 | 2024-05-16T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.